[1]
S. Pratiwi, A. Arfianti, S. Suyanto, and W. A. Fidiawati, “The Relationship Between Programmed Death-Ligand 1 and Cancer Stem Cells in Ovarian Cancer: Implications for Immunotherapy”, Asian Pac J Cancer Biol, vol. 11, no. 4, pp. 1181–1190, Oct. 2026.